Approximately one-third of Inserm's units are placed under the joint responsibility of another institution or public research organization.
Inserm's units are co-supervised by other institutions or public research organizations:
- Public research organizations:
- Other institutions:
Read as well: Inserm / CNRS framework agreement
Inserm and Aviesan, the French National Alliance for Life Sciences and Health
Inserm presides over the French National Alliance for Life Sciences and Health (Aviesan).
Aviesan, in short
Created in 2009, the Aviesan alliance has 19 members (and associate members): CEA, CNRS, Conférence des directeurs généraux de CHRU, Conférences des présidents d’université, INRA, INRIA, Inserm, Institut Pasteur, IRD, ARIIS (Alliance for research and innovation in the health industry), CIRAD, EFS, Fondation Mérieux, Ineris, Institut Curie, IRSN French Institute for Radiological Protection and Nuclear Safety (IRSN), French Armed Biomedical Research Institute (IRBA), Institut Mines-Télécom, Unicancer.
Its missions are to:
- coordinate the strategic analysis, scientific programming and operational implementation of research into life sciences and health;
- provide decision-making support for public policies; and
- define common positions for European research and international cooperation.
Every year, Aviesan works on the ANR action plan and its various challenges in keeping with the national research strategy. Aviesan's proposals rely on the work of multi-organization theme-based institutes that mobilize experts from every community and on the collegial work of the Aviesan council. Aviesan is also a member of the Scientific Steering Committee for the "Life, Health and Well-being" challenge, in charge of implementing the action plan.
Inserm manages Aviesan's governance bodies through:
- a executive board,
- a Aviesan council, and
- a Aviesan council open to associate members.
Inserm coordinates all responses on Aviesan's behalf: strategic guidance documents, steering committees for national plans and representation.
With the support of Aviesan's members, Inserm is a staunch advocate of biomedical research. It initiate new programs, positioning Aviesan as a key player. Some examples include the action plan for the programming of health research, the role of research in the National Health Data System, the French Plan for Genomic Medicine 2025, the research program for the control of antimicrobial resistance, and the structuring and coordination of the REACTing network, in particular for the control of the Ebola and Zika viruses.